Risk factors for new-onset chronic kidney disease in patients who have received a liver transplant

被引:12
作者
Li, Yuehong [1 ]
Li, Binbin [1 ]
Wang, Wei [1 ]
Lv, Jiaxuan [1 ]
机构
[1] Tsinghua Univ, Sch Clin Med, Dept Nephrol, Beijing Tsinghua Changgung Hosp, 168 Litang Rd, Beijing 102218, Peoples R China
关键词
calcineurin inhibitors; chronic kidney disease; liver transplantation; renal pathology; STAGE RENAL-DISEASE; CALCINEURIN-INHIBITORS; DYSFUNCTION; RECIPIENTS;
D O I
10.3892/etm.2018.5823
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to analyze the risk factors for new-onset chronic kidney disease (CKD) in patients who have received a liver transplant. A total of 190 patients who underwent liver transplantation between March 2001 and January 2015 were followed up, and analyzed retrospectively. Sex, age, primary disease, preoperative laboratory findings (hemoglobin, albumin, creatinine and glomerular filtration rate), surgical approach, blood loss during the surgery and transfusion volume, postoperative complications, and the average levels of calcineurin inhibitors (CNIs) (from liver transplantation to the onset of CKD) were analyzed. In total, 40 patients developed new-onset CKD after transplantation. Clinical data in the new-onset CKD group were compared with the non-CKD group. A 2 test, t-test and logistic regression analysis were performed using SPSS 17.0 software. The incidence of new-onset CKD after liver transplantation was 21.1%. Renal pathology included IgA nephropathy, hepatitis B virus-associated nephropathy, membranous proliferative glomerulonephritis, focal segmental glomerular sclerosis and cryoglobulinemia-associated renal injury. Among the CKD patients, 85.7% had tubulointerstitial damage. Univariate analysis showed that preoperative renal function, hemoglobin, intraoperative blood loss and transfusion volume, postoperative acute kidney injury, average levels of CNIs, and hypertension were risk factors for new-onset CKD after liver transplantation. Logistic regression analysis showed that preoperative glomerular filtration rate [odds ratio (OR)=0.980, P=0.041], hemoglobin (OR=0.972, P=0.034), average levels of CNIs (OR=1.364, P=0.015) and hypertension (OR=4.833, P=0.048)] were independent risk factors for new-onset CKD. The incidence of new-onset CKD in patients who received liver transplantation was high. The main risk factors were identified to be preoperative glomerular filtration rate, hemoglobin, postoperative average levels of CNIs and hypertension.
引用
收藏
页码:3589 / 3595
页数:7
相关论文
共 50 条
  • [21] New-Onset Diabetes After Kidney Transplantation: Prevalence, Risk Factors, and Management
    Sarno, Gerardo
    Muscogiuri, Giovanna
    De Rosa, Paride
    TRANSPLANTATION, 2012, 93 (12) : 1189 - 1195
  • [22] Pre-transplant Kidney Function Predicts Chronic Kidney Disease After Liver Transplant: Meta-Analysis of Observational Studies
    Fabrizi, Fabrizio
    Dixit, Vivek
    Martin, Paul
    Messa, Piergiorgio
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (05) : 1282 - 1289
  • [23] Relations of residential green and blue spaces with new-onset chronic kidney disease
    Liu, Mengyi
    Ye, Ziliang
    He, Panpan
    Yang, Sisi
    Zhang, Yanjun
    Zhou, Chun
    Zhang, Yuanyuan
    Gan, Xiaoqin
    Qin, Xianhui
    SCIENCE OF THE TOTAL ENVIRONMENT, 2023, 869
  • [24] Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Bakris, George L.
    Pitt, Bertram
    Agarwal, Rajiv
    Rossing, Peter
    Ruilope, Luis M.
    Butler, Javed
    Lam, Carolyn S. P.
    Kolkhof, Peter
    Roberts, Luke
    Tasto, Christoph
    Joseph, Amer
    Anker, Stefan D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (02) : 142 - 152
  • [25] Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Lin, Yu-Ling
    Lin, Sheng-Hsiang
    Wang, Hsi-Hao
    Hsu, Wan-Chia
    Hung, Shih-Yuan
    Chiou, Yuan-Yow
    Liou, Hung-Hsiang
    Chang, Min-Yu
    Ho, Li-Chun
    Wu, Ching-Fang
    Lee, Yi-Che
    PHARMACEUTICALS, 2025, 18 (01)
  • [26] An Analysis of the Risk Factors for New-Onset Diabetes Mellitus After Liver Transplantation
    Sun, Jushan
    He, Yibiao
    Bai, Lei
    Wang, Zhipeng
    Cao, Zhu
    Shao, Yingmei
    Zhao, Jinming
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 4783 - 4792
  • [27] Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: Results of a pilot study
    Lorho, R.
    Hardwigsen, J.
    Dumortier, J.
    Pageaux, G. -P.
    Durand, F.
    Bizollon, T.
    Blanc, A. -S.
    Di Giambattista, F.
    Duvoux, C.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (6-7) : 482 - 488
  • [28] Anemia and atrial fibrillation as independent risk factors for new-onset chronic kidney disease: the TAMA-MED Project-CKD and AF
    Kaneko, Tomohiro
    Kodani, Eitaro
    Fujii, Hitomi
    Asai, Risa
    Seki, Miyako
    Nakazato, Rei
    Nakamura, Hiroyuki
    Sasabe, Hajime
    Tamura, Yutaka
    CLINICAL KIDNEY JOURNAL, 2021, 14 (10) : 2221 - 2226
  • [29] Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant
    Wong, Germaine
    Li, Margaret W. Y.
    Howard, Kirsten
    Hua, Danny K.
    Chapman, Jeremy R.
    Bourke, Michael
    Turner, Robin
    Tong, Allison
    Craig, Jonathan C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (04) : 917 - 926
  • [30] End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease
    Bahirwani, Ranjeeta
    Forde, Kimberly A.
    Mu, Yifei
    Lin, Fred
    Reese, Peter
    Goldberg, David
    Abt, Peter
    Reddy, K. Rajender
    Levine, Matthew
    CLINICAL TRANSPLANTATION, 2014, 28 (02) : 205 - 210